As part of your daily routine as an active trader or investor, it's important to track the stocks in the market that are making the biggest percentage gains and the biggest percentage losses.

Stocks that are making large moves to the upside are favorites among short-term traders who want to capture some of that massive volatility. Stocks that are making big-percentage moves are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Stocks that are in favor and making large moves is a segment of the market that I tweet about on a regular basis.These are also the exact type of stocks that I love to trade and alert to my subscribers in real-time.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Dicerna Pharmaceuticals

  • Tuesday's Range: $2.71-$3.50
  • 52-Week Range: $2.69-$15.93
  • Tuesday's Volume: 2.28 million
  • Three-Month Average Volume: 164,418

Dicerna Pharmaceuticals  (DRNA - Get Report) , a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers based on a proprietary RNA interference technology platform in the U.S. and internationally. This stock closed up 17% to $3.16 in Tuesday's trading session.

From a technical perspective, Dicerna Pharmaceuticals exploded higher on Tuesday right off its new 52-week low of $2.69 a share with monster upside volume flows. This high-volume rip to the upside is now quickly pushing shares of Dicerna Pharmaceuticals within range of triggering a major breakout trade above some key near-term overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $3.50 to $3.54 a share and then above its 50-day moving average of $3.84 a share with high volume.

Traders should now look for long-biased trades in Dicerna Pharmaceuticals long as it's trending above its new 52-week low of $2.69 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 164,418 shares. If that breakout triggers soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $4.09 to $4.12, or even $5.50 to $6 a share.

Genocea Biosciences

  • Tuesday's Range: $3.92-$4.77
  • 52-Week Range: $2.56-$16.18
  • Tuesday's Volume: 2.86 million
  • Three-Month Average Volume: 1.45 million

Genocea Biosciences  (GNCA) , a biopharmaceutical company, discovers and develops novel vaccines and immunotherapies to treat infectious diseases. This stock traded up 14.2% to $4.41 in Tuesday's trading session.

From a technical perspective, Genocea Biosciences ripped sharply higher on Tuesday right above some near-term support at $3.76 a share and back above both its 20-day moving average of $4.21 a share and its 50-day moving average of $4.22 a share with strong upside volume flows. This high-volume rip to the upside is now quickly pushing shares of Genocea Biosciences within range of triggering a near-term breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $4.89 to its 200-day moving average of $5.14 a share and then above more resistance at $5.20 a share with high volume.

Traders should now look for long-biased trades in Genocea Biosciences as long as it's trending above $4 a share or above Tuesday's intraday low of $3.92 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.45 million shares. If that breakout hits soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at around $5.50 to $6, or even $6.50 to $7 a share.

Chimerix

  • Tuesday's Range: $3.62-$3.84
  • 52-Week Range: $3.49-$58.04
  • Tuesday's Volume: 1.43 million
  • Three-Month Average Volume: 1.13 million

Chimerix  (CMRX - Get Report) , a biopharmaceutical company, discovers, develops and commercializes oral antivirals in the areas of unmet medical needs in the U.S. This stock traded up 7% to $3.81 in Tuesday's trading session.

From a technical perspective, Chimerix spiked sharply higher on Tuesday right above its new 52-week low of $3.49 a share with above-average volume. This stock has been downtrending badly over the last three months, with shares moving lower off its high of $6.47 a share to its new 52-week low of $3.49 a share. During that downtrend, shares of Chimerix have been consistently making lower highs and lower lows, which is bearish technical price action. That said, this stock has now started to rebound off that $3.49 low, and it's quickly trending within range of triggering a near-term breakout trade. That trade will trigger if this stock manages to take out Tuesday's intraday high of $3.84 a share to some more near-term resistance at $4 a share with high volume.

Traders should now look for long-biased trades in Chimerix as long as it's trending above Tuesday's intraday low of $3.62 a share or above its new 52-week low of $3.49 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.13 million shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 20-day moving average of $4.17 to $4.50, or even its 50-day moving average of $4.83 to $5 a share.

TerraForm Power

TerraForm Power  (TERP - Get Report)  owns and operates solar and wind generation assets serving utility, commercial and residential customers. This stock traded up 4.7% to $8.75 in Tuesday's trading session.

  • Tuesday's Range: $8.30-$8.89
  • 52-Week Range: $6.73-$40.24
  • Tuesday's Volume: 3.28 million
  • Three-Month Average Volume: 2.85 million

From a technical perspective, TerraForm Power spiked notably higher on Tuesday back above its 20-day moving average of $8.45 a share with strong upside volume flows. This high-volume bump to the upside is now quickly pushing shares of TerraForm Power within range of triggering a near-term breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to take out Tuesday's intraday high of $8.89 a share and then above its 50-day moving average of $9.14 share to some more near-term resistance levels at $9.19 to $9.27 a share with high volume.

Traders should now look for long-biased trades in TerraForm Power as long as it's trending above Tuesday's intraday low of $8.30 a share or above more near-term support at $7.95 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 2.85 million shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $9.70 to $10, or even $10.50 to $11 a share.

ProNAi Therapeutics

  • Tuesday's Range: $1.89-$2.03
  • 52-Week Range: $1.85-$33.75
  • Tuesday's Volume: 943,000
  • Three-Month Average Volume: 732,171

ProNAi Therapeutics  (DNAI) , a clinical-stage oncology company, develops and commercializes drugs based on its DNA interference technology platform for patients with cancer and hematological malignancies. This stock traded up 5.8% to $1.99 in Tuesday's trading session.

From a technical perspective, ProNAi Therapeutics spiked sharply higher on Tuesday right off its new 52-week low of $1.85 a share with above-average volume. This stock recently formed a double bottom chart pattern, after shares found some buying interest at $1.86 to $1.85 a share over the last month. Following that potential bottom, shares of ProNAi Therapeutics have now started to rip higher off those support levels, and it's now quickly trending within range of triggering a big breakout trade. That trade will trigger if this stock manages to take out Tuesday's intraday high of $2.03 a share and then once it clears more key resistance levels at $2.13 to $2.18 a share with high volume.

Traders should now look for long-biased trades in ProNAi Therapeutics as long as it's trending above those recent double bottom support levels and then once it sustains a move or close above those breakout levels with volume that registers near or above 732,171 shares. If that breakout kicks off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 20-day moving average of $2.66 a share to its gap-down-day high from earlier this month around $3 a share.

J.C. Penney

  • Tuesday's Range: $8.48-$8.75
  • 52-Week Range: $6.00-$11.99
  • Tuesday's Volume: 14.90 million
  • Three-Month Average Volume: 14.72 million

J.C. Penney  (JCP - Get Report)  sells merchandise through department stores in the U.S. This stock traded up 3% to $8.69 in Tuesday's trading session.

From a technical perspective, J.C. Penney trended notably higher on Tuesday right off its 50-day moving average of $8.46 a share and back above its 200-day moving average of $8.68 a share with above-average volume. This stock recently formed a double bottom chart pattern, after shares found some buying interest at $7.91 to $8.01 a share over the last few weeks. Following that potential bottom, shares of J.C. Penney have now started to trend higher and move within range of triggering a near-term breakout trade. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $8.75 to $8.87 a share and then above more resistance around $9 a share with high volume.

Traders should now look for long-biased trades in J.C. Penney as long as it's trending above its 20-day moving average of $8.38 a share or above those recent double bottom support levels and then once it sustains a move or close above those breakout levels with volume that hits near or above 14.72 million shares. If that breakout takes hold soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $9.75 to $9.84, or even $10.12 to $10.50 a share.

Barclays 

  • Tuesday's Range: $7.13-$7.39
  • 52-Week Range: $6.76-$18.05
  • Tuesday's Volume: 63,29 million
  • Three-Month Average Volume: 8.46 million

Barclays (BCS)  provides various financial products and services worldwide. This stock traded up 3.8% to $7.30 in Tuesday's trading session.

From a technical perspective, Barclays PLC jumped sharply higher on Tuesday with monster upside volume flows. This stock recently gapped-down sharply lower from $11.19 a share to its new 52-week low of $6.76 a share with massive downside volume. Following that move, shares of Barclays PLC have now started to rebound off that $6.76 low, and it's started to trend back into that gap-down-day zone just above $7 a share. Market players should now look for a continuation move to the upside in the short-term if shares of Barclays PLC manage to clear Tuesday's intraday high of $7.39 a share with high-volume.

Traders should now look for long-biased trades in Barclays PLC as long as it's trending above Tuesday's intraday low of $7.13 a share or above its new 52-week low of $6.76 a share and then once it sustains a move or close above Tuesday's intraday high of $7.39 a share with volume that hits near or above 8.46 million shares. If that move gets underway soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $8.20 to around $9.15 to $9.50 a share.

Disclosure: This article is commentary by an independent contributor. At the time of publication, the author was long DRNA.